Loading…
avatar for Frederick Derosier

Frederick Derosier

Covance
Executive Director, Rare Diseases
Dr. Frederick Derosier, D.O., joined Covance Inc. as an Executive Medical director for Rare Diseases in 2017 and has over 10 years of private practice experience (internal medicine) and nearly 19 years of clinical development experience, primarily in neurosciences and rare diseases, in the pharmaceutical industry. Dr. Derosier’s experience broadly extends from translational/early phase development through product launch to late-phase/post marketing studies and life-cycle management. He provides medical/scientific leadership for rare diseases at Covance and serves as the chair of the Advanced Therapies, Drugs, and Devices Development (ATD3) pan-enterprise (Covance and LabCorp) group.